Efficacy and Safety of Palbociclib and Fulvestrant in Japanese Patients With ER+/HER2– Advanced/Metastatic Breast Cancer

Background/Aim: Published data have shown that palbociclib-fulvestrant can significantly improve the progression-free survival (PFS) of estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) metastatic breast cancer patients, but not of Japanese patients. We conduct...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:In Vivo
Prif Awduron: SEKI, HIROHITO, SAKURAI, TAKASHI, MAEDA, YUKA, OKI, NAOHIKO, AOYAMA, MINA, YAMAGUCHI, RYOU, TOKUDA, TOSHIKI, KABURAGI, TAKUJI, OKUMURA, TAKEHIRO, KARAHASHI, TSUYOSHI, NAKAJIMA, KENICHIRO, HIGETA, KAORI, SHIMIZU, KEN
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: International Institute of Anticancer Research 2019
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899113/
https://ncbi.nlm.nih.gov/pubmed/31662535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11701
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg